ADVERTISEMENT
Graphic depicting a tumor being targeted by a drug.
Great Anticancer Potential Comes in a Small Package 
Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.
Great Anticancer Potential Comes in a Small Package 
Great Anticancer Potential Comes in a Small Package 

Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.

Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.

combination therapy

Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
Shawna Williams | Nov 1, 2018 | 5 min read
A small pilot study suggests the approach can identify effective treatments already approved for other cancers.
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018 | 2 min read
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
Two Experimental Drugs Reduce Infections in the Elderly
Sukanya Charuchandra | Jul 12, 2018 | 2 min read
Despite the treatment being given for only six weeks, the positive effects lasted for a year.
Immune Therapy Improves Lung Cancer Patientsā€™ Survival
Jim Daley | Apr 16, 2018 | 2 min read
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018 | 9 min read
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
FDA Approves Clinical Trials to Test Cuban Cancer Vaccine
Bob Grant | Oct 31, 2016 | 2 min read
An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.
Chemotherapy Pioneer Dies
Dan Cossins | May 6, 2013 | 1 min read
Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
Tuberculosis Trial Launched
Hannah Waters | Mar 20, 2012 | 1 min read
The TB Alliance will test a new combination of drugs to combat normal and multi-drug-resistant tuberculosis.
ADVERTISEMENT